Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinox With or Without Trastuzumab in Advanced Breast Cancer
NCT00403988Phase 2Terminated
- Sponsor
- American University of Beirut Medical Center
- Start
- Jun 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, vinorelbine in breast cancer, sponsored by American University of Beirut Medical Center. Started Jun 2004; status: terminated.
02
Drugs
oxaliplatinvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00403988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403988.